Home / Stocks / ADLINE
Back to all stocks
BSE · ADLINE

ADLINE CHEM LAB LIMITED (ADLINE) Share Price

Sector: Healthcare · ISIN: INE276T01018

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,613
of 5,047 stocks
▼ 191W▼ 161M
Peak #4,557 · 02 Oct 2026

A microcap name in Healthcare, ADLINE CHEM LAB LIMITED carries a steep earnings multiple that prices in strong future growth, has a widely-held ownership base, with promoters at just 26%, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap
9.24 Cr
P/E Ratio
789.50
P/B Ratio
—
ROE
8.88%
ROCE
-124.17%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q3 2025-26Q1 2025-26
RevenueRs 0Rs 0Rs 0Rs 0
Net Profit-8.75 L4.01 L-6.46 L-5.13 L
EPS-0.150.070.010.01
Operating Profit-3.21 L8.04 L-3.00 L-3.10 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
25.85%
Public
74.15%

PUBLIC BREAKDOWN

Individuals
73.55%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs